Medical Condition News

RSS

Skiing associated with reduced risk of vascular dementia but not Alzheimer’s

Half as many diagnosed with depression, a delayed manifestation of Parkinson's, a reduced risk of developing vascular dementia - but not Alzheimer's.

26 Nov 2019

Aerobic exercise and heart-healthy diet may slow cognitive decline in older adults with CIND

Cognitive impairment without dementia (CIND), or mild cognitive impairment, is a condition that affects your memory and may put you at risk for Alzheimer's disease and dementia.

26 Nov 2019

Study reveals novel pathway to target colorectal cancer

While the emergence of precision medicine and immunotherapy has greatly improved outcomes for patients with colorectal cancer, new approaches are still needed for patients with late-stage disease who do not respond to these therapies.

26 Nov 2019

Researchers win grants to find innovative treatments for debilitating skin diseases

National leaders in research to cure debilitating skin diseases based at the Gates Center for Regenerative Medicine on the University of Colorado Anschutz Medical Campus have won a second NIH grant to further investigations of innovative treatments.

26 Nov 2019

Kessler Foundation participates in new study to test innovative treatment for hand paralysis

Kessler Foundation is participating in a phase II multi-site study of an innovative treatment to improve hand function in stroke survivors. Olga Boukrina, PhD, research scientist in the Center for Stroke Rehabilitation Research, is the site's principal investigator.

26 Nov 2019

Mcl-1 inhibition blocks cell survival in ER+ breast cancers

While estrogen receptor - + breast cancers express high levels of three anti-apoptotic Bcl-2 family members, pharmacological inhibition of Bcl-2 and/or Bcl-xL fails to induce cell death in ER + breast cancer cell lines, due to rapid and robust Mcl-1 upregulation.

26 Nov 2019

Giving a shot of ketamine could help heavy drinkers reduce alcohol intake

A one-off dose of ketamine could help heavy drinkers reduce their alcohol intake, finds a new UCL experimental study.

26 Nov 2019

Innovative migraine prophylaxis could endanger people with chronic high blood pressure

The neuropeptide αCGRP (α calcitonin gene-related peptide) works in two different ways. It leads to inflammation and dilates the blood vessels right at the release point of the nerve cells, for example in the meninges, which can trigger migraine attacks. However, it has a completely different effect on the heart, as has now been discovered by a team of researchers at the University of Zurich.

26 Nov 2019

Broadly expressed metabolic approach could make sarcoma susceptible to targeted therapies

Soft tissue sarcoma cells stop a key metabolic process which allows them to multiply and spread, and so restarting that process could leave these cancers vulnerable to a variety of treatments.

26 Nov 2019

Targeting molecular mechanisms could be beneficial in diabetic wound care

When our skin is damaged, a whole set of biological processes springs into action to heal the wound. Now, researchers from the VIB-UGent Center for Inflammation Research have shown that one of the molecules involved in this, HMGB1, slows down wound healing.

26 Nov 2019

Sheffield research receives £800k to develop new gene therapy to treat CVD

Cardiac research in Sheffield has received a major boost from the British Heart Foundation in the form of an £800,000 award to develop a new gene therapy to treat cardiovascular disease (CVD).

26 Nov 2019

Key mechanism identified for how antiviral immune responses reprogram liver metabolism

Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences identified a key mechanism for how antiviral immune responses reprogram liver metabolism. Their recent study, which was published in the renowned scientific journal Immunity, investigated the communication between inflammation and liver metabolism during chronic viral infection.

26 Nov 2019

Newly developed personalized vaccine system could delay onset of pancreatic cancer

Researchers from Queen Mary University of London and Zhengzhou University have developed a personalized vaccine system that could ultimately delay the onset of pancreatic cancer. The study provides strong proof-of-concept for the creation of a vaccine for cancer prevention in individuals at high risk of developing this disease and to slow down tumor growth in patients who are affected by it.

26 Nov 2019

New method for correcting hypoxic conditions of the central nervous system

Hypoxia is a key factor that accompanies most brain pathologies, including ischemia and neurodegenerative diseases.

26 Nov 2019

Studying the genomes of hibernating mammals could improve understanding and treatment of obesity

A discovery about mammalian genomes and hibernation could aid understanding and treatment of obesity and metabolic disorders.

26 Nov 2019

Researchers find new way to protect against disease in MS model

Researchers have found a new and unexpected way of preventing disease in a preclinical model of multiple sclerosis (MS).

26 Nov 2019

Study demonstrates potential therapeutic use of ketamine for alcohol addiction

A study shows one-off dose of ketamine could help heavy drinkers reduce alcohol intake by ‘erasing’ drink-related memories.

26 Nov 2019

New method to separate two variants of common herpes virus linked to multiple sclerosis

Researchers at Karolinska Institutet have developed a new method to separate between two different types of a common herpes virus that has been linked to multiple sclerosis.

26 Nov 2019

Novoheart collaborates with AstraZeneca to develop world’s first human heart-in-a-jar model of heart failure

Novoheart, a global stem cell biotechnology company, is pleased to announce a collaboration with global biopharmaceutical company AstraZeneca, in an effort to develop the world’s first human-specific in vitro, functional model of heart failure with preserved ejection fraction (HFpEF), a common condition especially among the elderly and in women, with the reported prevalence approaching 10% in women over the age of 80 years.

26 Nov 2019

A young immigrant has mental illness, and that’s raising his risk of deportation

When José moved his family to the United States from Mexico nearly two decades ago, he had hopes of giving his children a better life.

26 Nov 2019

Medical Condition News

Skiing associated with reduced risk of vascular dementia but not Alzheimer’s

Aerobic exercise and heart-healthy diet may slow cognitive decline in older adults with CIND

Study reveals novel pathway to target colorectal cancer

Researchers win grants to find innovative treatments for debilitating skin diseases

Kessler Foundation participates in new study to test innovative treatment for hand paralysis

Mcl-1 inhibition blocks cell survival in ER+ breast cancers

Giving a shot of ketamine could help heavy drinkers reduce alcohol intake

Innovative migraine prophylaxis could endanger people with chronic high blood pressure

Broadly expressed metabolic approach could make sarcoma susceptible to targeted therapies

Targeting molecular mechanisms could be beneficial in diabetic wound care

Sheffield research receives £800k to develop new gene therapy to treat CVD

Key mechanism identified for how antiviral immune responses reprogram liver metabolism

Newly developed personalized vaccine system could delay onset of pancreatic cancer

New method for correcting hypoxic conditions of the central nervous system

Studying the genomes of hibernating mammals could improve understanding and treatment of obesity

Researchers find new way to protect against disease in MS model

Study demonstrates potential therapeutic use of ketamine for alcohol addiction

New method to separate two variants of common herpes virus linked to multiple sclerosis

Novoheart collaborates with AstraZeneca to develop world’s first human heart-in-a-jar model of heart failure

A young immigrant has mental illness, and that’s raising his risk of deportation

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News